Elisabeth Chereau

Marseille, 13005, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

Borderline ovarian tumors: French guidelines from the CNGOF. Part 1. Epidemiology, biopathology, imaging and biomarkers.

Borderline ovarian tumors: French guidelines from the CNGOF. Part 1. Epidemiology, biopathology, imaging and biomarkers.

Journal: Journal of gynecology obstetrics and human reproduction

Published: November 07, 2020

Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF).

Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF).

Journal: European journal of obstetrics, gynecology, and reproductive biology

Published: October 28, 2020

Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Diagnosis and Management of Recurrent Borderline Ovarian Tumours

Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Diagnosis and Management of Recurrent Borderline Ovarian Tumours

Journal: Gynecologie, obstetrique, fertilite & senologie

Published: February 01, 2020

Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Epidemiology and Risk Factors of Relapse, Follow-up and Interest of a Completion Surgery

Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Epidemiology and Risk Factors of Relapse, Follow-up and Interest of a Completion Surgery

Journal: Gynecologie, obstetrique, fertilite & senologie

Published: February 01, 2020

Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Short Text

Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Short Text

Journal: Gynecologie, obstetrique, fertilite & senologie

Published: February 01, 2020

Value of Diaphragmatic Surgery During Interval Debulking Surgery.

Value of Diaphragmatic Surgery During Interval Debulking Surgery.

Journal: Anticancer research

Published: October 09, 2017

Primary management of endometrial carcinoma. Joint recommendations of the French society of gynecologic oncology (SFOG) and of the French college of obstetricians and gynecologists (CNGOF)

Primary management of endometrial carcinoma. Joint recommendations of the French society of gynecologic oncology (SFOG) and of the French college of obstetricians and gynecologists (CNGOF)

Journal: Gynecologie, obstetrique, fertilite & senologie

Published: September 21, 2017

Evaluation and Selection of Quality Indicators for the Management of Endometrial Cancer.

Evaluation and Selection of Quality Indicators for the Management of Endometrial Cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: May 13, 2017

Efficacy and safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Results from the ANTHALYA trial.

Efficacy and safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Results from the ANTHALYA trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 15, 2016

Dynamic Analysis of CA125 Decline During Neoadjuvant Chemotherapy in Patients with Epithelial Ovarian Cancer as a Predictor for Platinum Sensitivity.

Dynamic Analysis of CA125 Decline During Neoadjuvant Chemotherapy in Patients with Epithelial Ovarian Cancer as a Predictor for Platinum Sensitivity.

Journal: Anticancer research

Published: January 22, 2016

Clinical practice guidelines from the French College of Gynecologists and Obstetricians (CNGOF): benign breast tumors - short text.

Clinical practice guidelines from the French College of Gynecologists and Obstetricians (CNGOF): benign breast tumors - short text.

Journal: European journal of obstetrics, gynecology, and reproductive biology

Published: December 08, 2015

Evaluation of the Effects of Pasireotide LAR Administration on Lymphocele Prevention after Axillary Node Dissection for Breast Cancer: Results of a Randomized Non-Comparative Phase 2 Study.

Evaluation of the Effects of Pasireotide LAR Administration on Lymphocele Prevention after Axillary Node Dissection for Breast Cancer: Results of a Randomized Non-Comparative Phase 2 Study.

Journal: PloS one

Published: November 30, 2015

Showing 1-12 of 52

Last Updated: 09/26/2026